Exact Sciences Shares Plunge Amid Weak Results and Downgraded Guidance
Daily NewsMADISON, Wis. - Shares of Exact Sciences Corp. (NASDAQ:EXAS), a provider of cancer screening and diagnostic tests, fell 25% following third-quarter results that m...
Read More